Article
Feeds
|
New Jersey Intermediate Appellate Court Splits Pre-emption Rulings in Vioxx Case |
June 25, 2008
Previously published on June 9, 2008
On May 29, 2008, New Jersey's intermediate appellate court stepped into the pre-emption fray and decided that state law failure-to-warn claims challenging the adequacy of prescription drug labeling are not pre-empted under the Food, Drug and Cosmetic Act ("FDCA") whereas the...
|
The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
|
|